These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27146492)

  • 1. Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study.
    Wells KJ; Pan TM; Vázquez-Otero C; Ung D; Ustjanauskas AE; Muñoz D; Laronga C; Roetzheim RG; Goldenstein M; Carrizosa C; Nuhaily S; Johnson K; Norton M; Sims E; Quinn GP
    Support Care Cancer; 2016 Oct; 24(10):4123-30. PubMed ID: 27146492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitators of Survivorship Care Among Underserved Breast Cancer Survivors: a Qualitative Study.
    Ustjanauskas AE; Quinn GP; Pan TM; Rivera M; Vázquez-Otero C; Ung D; Roetzheim RG; Laronga C; Johnson K; Norton M; Carrizosa C; Muñoz D; Goldenstein M; Nuhaily S; Wells KJ
    J Cancer Educ; 2017 Dec; 32(4):756-763. PubMed ID: 27385123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study.
    Bluethmann SM; Murphy CC; Tiro JA; Mollica MA; Vernon SW; Bartholomew LK
    Oncol Nurs Forum; 2017 May; 44(3):E101-E110. PubMed ID: 28635973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated with Endocrine Therapy Non-Adherence in Breast Cancer Survivors.
    Spencer JC; Reeve BB; Troester MA; Wheeler SB
    Psychooncology; 2020 Apr; 29(4):647-654. PubMed ID: 32048400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Breast Cancer Survivors' Beliefs and Concerns About Adjuvant Hormonal Therapy: Promoting Adherence.
    Hurtado-de-Mendoza A; Jensen RE; Jennings Y; Sheppard VB
    J Cancer Educ; 2018 Apr; 33(2):436-439. PubMed ID: 28205022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators to adherence to secondary stroke prevention medications after stroke: analysis of survivors and caregivers views from an online stroke forum.
    Jamison J; Sutton S; Mant J; De Simoni A
    BMJ Open; 2017 Jul; 7(7):e016814. PubMed ID: 28713074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding tamoxifen adherence in women with breast cancer: A qualitative study.
    Moon Z; Moss-Morris R; Hunter MS; Hughes LD
    Br J Health Psychol; 2017 Nov; 22(4):978-997. PubMed ID: 28850763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?
    Ekinci E; Nathoo S; Korattyil T; Vadhariya A; Zaghloul HA; Niravath PA; Abughosh SM; Trivedi MV
    J Cancer Surviv; 2018 Jun; 12(3):348-356. PubMed ID: 29396760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data.
    Sheppard VB; He J; Sutton A; Cromwell L; Adunlin G; Salgado TM; Tolsma D; Trout M; Robinson BE; Edmonds MC; Bosworth HB; Tadesse MG
    J Manag Care Spec Pharm; 2019 May; 25(5):578-586. PubMed ID: 31039059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mixed-methods study of the technical feasibility and patient acceptability of a real-time adherence monitor in breast cancer survivors taking adjuvant endocrine therapy.
    Bright EE; Genung SR; Stanton AL; Arch JJ
    Breast Cancer Res Treat; 2022 Oct; 195(3):393-399. PubMed ID: 35962148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine therapy adherence: a cross-sectional study of factors affecting adherence and discontinuation of therapy.
    Quinn EM; Fleming C; O'Sullivan MJ
    Ir J Med Sci; 2016 May; 185(2):383-92. PubMed ID: 25971465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.
    Murphy CC; Bartholomew LK; Carpentier MY; Bluethmann SM; Vernon SW
    Breast Cancer Res Treat; 2012 Jul; 134(2):459-78. PubMed ID: 22689091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.
    Tan X; Camacho F; Marshall VD; Donohoe J; Anderson RT; Balkrishnan R
    Res Social Adm Pharm; 2017; 13(4):796-810. PubMed ID: 27641308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors.
    Brier MJ; Chambless DL; Gross R; Chen J; Mao JJ
    Cancer; 2017 Jan; 123(1):169-176. PubMed ID: 27570979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory.
    AlOmeir O; Patel N; Donyai P
    Support Care Cancer; 2020 Nov; 28(11):5075-5084. PubMed ID: 32601852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer.
    Bright EE; Petrie KJ; Partridge AH; Stanton AL
    Breast Cancer Res Treat; 2016 Jul; 158(2):243-51. PubMed ID: 27342455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence status to Adjuvant Endocrine Therapy in Chinese Women with Early Breast Cancer and its influencing factors: A cross-sectional survey.
    Xu H; Jin F; Zhang XJ; Wang DQ; Yu SF; Wang AP
    Cancer Med; 2020 Jun; 9(11):3703-3713. PubMed ID: 32237070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy use among Appalachian breast cancer survivors.
    Tan X; Marshall VD; Anderson RT; Donohoe J; Camacho F; Balkrishnan R
    Medicine (Baltimore); 2015 Jul; 94(26):e1071. PubMed ID: 26131828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.
    Lambert LK; Balneaves LG; Howard AF; Gotay CC
    Breast Cancer Res Treat; 2018 Feb; 167(3):615-633. PubMed ID: 29110151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence.
    Pourcelot C; Orillard E; Nallet G; Dirand C; Billion-Rey F; Barbier G; Chouk S; Limat S; Montcuquet P; Henriques J; Paget-Bailly S; Anota A; Chaigneau L; Nerich V
    Breast Cancer Res Treat; 2018 May; 169(1):153-162. PubMed ID: 29362956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.